From Awareness to Action: Pioneering Solutions for Women's UTI Challenges in the Era of Precision Medicine
Emery Haley,Natalie Luke
DOI: https://doi.org/10.2147/ijwh.s477476
2024-09-29
International Journal of Women s Health
Abstract:Emery Haley, Natalie Luke Department of Clinical Research, Pathnostics, Irvine, CA, USA Correspondence: Natalie Luke, Pathnostics, 15545 Sand Canyon Suite 100, Irvine, CA, 92618, USA, Tel +1-714-966-1221, Fax +1-714-966-1231, Email This article aims to bring clinicians' awareness to the widespread impact of urinary tract infection (UTI) on the lives of women and to the advances that offer hope for future improvements in the diagnosis and management of UTI. Thanks to physiological, anatomical, and lifestyle factor differences, women face heightened vulnerability to UTIs compared to men. In fact, women are four times more likely than men to develop a UTI and around half of these women encounter UTI recurrence, which is a significant source of both physical and psychosocial burdens. Despite the current shortcomings in diagnosis and management, emerging diagnostic technologies promise to identify UTIs more accurately and rapidly, offering women hope for a revolution in UTI management. Meanwhile, clinicians have the opportunity to reduce the psychosocial burden by recognizing the value of patients' lived experiences and ensuring their care plan is in alignment with their patients' goals and expectations for medical care. Keywords: women's health, urinary tract infection, urine culture, multiplex-polymerase chain reaction, metagenomic next-generation sequencing, mass spectrometry UTIs occur anywhere from the urethra to the kidneys, manifesting as cystitis or pyelonephritis based on the infection's location. 1 The symptoms vary between individuals, but commonly cause physical discomfort and pose substantial psychosocial challenges, impacting women's daily lives. UTIs can be conceptualized as falling into a diagnostic spectrum, with varying clinical signs and symptoms. 2 Signs and symptoms of UTI may overlap with other urologic diagnoses, such as incontinence, overactive bladder (OAB), or interstitial cystitis (IC), a.k.a. bladder pain syndrome (BPS). 3,4 Furthermore, distinguishing UTI symptoms can be a significant challenge, especially in long-term care facilities, where residents experience high rates of both asymptomatic bacteriuria (ASB) (up to 80%) 5,6 and cognitive impairment. 7 For example, individuals with Alzheimer's disease, dementia, or other forms of cognitive impairments may be unable to clearly communicate their symptoms. In addition, many older individuals do not experience typical UTI symptoms, including urinary frequency, urinary urgency, and dysuria. In fact, atypical symptoms of UTI, which include nonspecific declines in cognitive or physical function, are frequently the only symptoms in elderly individuals. 8–10 Young children and individuals with disabilities, such as paralysis, are also likely to face diagnostic challenges due to difficulties in recognizing UTI symptoms. Therefore, advanced methods to distinguish infection and inflammation from healthy eubiosis are desperately needed to avoid unnecessary and potentially detrimental treatment resulting from confusing ASB with UTI in these vulnerable populations. The diagnosis of a clinical UTI requires both the presence of symptoms and the confirmation of uropathogenic microorganisms in the urine. The term ASB has been used to describe the presence of bacteria in the urinary tract in the absence of any clinical urinary symptoms. 5 The prevalence of ASB in non-catheterized individuals has been reported to range from < 1–50% depending on sex and age. 11 Historically, because healthy urine was presumed to be sterile, ASB was thought to require treatment. 5 However, evidence that antibiotic treatment of ASB fails to produce a clinical benefit suggests that the presence of bacteriuria in the absence of symptoms should not be treated. 11–13 One exception relevant to women is during pregnancy, when treatment of ASB may be recommended to reduce risks of maternal pyelonephritis, pre-term labor, and/or low birth weight. 14 Limitations in standard urine culture (SUC) have upheld the misconception that urine is sterile. SUC methodology is biased toward detecting classical gram-negative uropathogens, such as Escherichia coli ( E. coli ). Culture-independent, molecular-based methods have now revealed that SUC fails to reproducibly detect the majority of the urobiome. 15–18 Advances in the analysis of microbial communities over the last decade have demonstrated that the urinary tract, particularly the bladder, is home to a resident microbiota, referred to as the urobiome. 13,19–22 The use of next-generation sequencing has revealed that the urobiome, while distinct, exhibits similarities to the microbiomes of the genital skin and/or vaginal mucosa. 23–25 The urobiome has also been shown to chang -Abstract Truncated-
obstetrics & gynecology